{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:11:07Z","timestamp":1792631467427,"version":"4.5.0"},"reference-count":31,"publisher":"MDPI AG","issue":"14","license":[{"start":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T00:00:00Z","timestamp":1721174400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>Systemic sclerosis (SSc) is an autoimmune connective tissue disease with a triad of features that include vascular abnormalities, inflammation and skin and lung fibrosis. At the core of the disease is the activation of myofibroblasts from quiescent fibroblasts and this can be modified by various cytokines. IL-41 is a recently described cytokine that was initially characterised as an adipokine as it was highly expressed in adipocytes and adipose tissue. However, it has recently been identified as being widely expressed and has immunomodulatory functions. This study examined the circulating levels of IL-41 and its expression in skin biopsies. We demonstrated significantly reduced levels of IL-41 in diffuse SSc that was also mirrored in the skin of SSc patients. AMPK has been proposed as a downstream target of IL-41, so we also measure mammalian target of rapamycin in skin and found that this is elevated in SSc patients. We speculate that IL-41 maybe an antifibrotic cytokine and its reduction may facilitate the activation of fibroblasts.<\/jats:p>","DOI":"10.3390\/cells13141205","type":"journal-article","created":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T12:29:43Z","timestamp":1721219383000},"page":"1205","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The Novel Cytokine Interleukin-41\/Meteorin-like Is Reduced in Diffuse Systemic Sclerosis"],"prefix":"10.3390","volume":"13","author":[{"given":"Paul","family":"Freedman","sequence":"first","affiliation":[{"name":"Department of Biosciences, Durham University, South Road, Durham DH1 3LE, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1433-0188","authenticated-orcid":false,"given":"Bettina","family":"Schock","sequence":"additional","affiliation":[{"name":"The Wellcome-Wolfson Institute for Experimental Medicine, Queens University Belfast, Belfast BT9 7BL, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"O\u2019Reilly","sequence":"additional","affiliation":[{"name":"Department of Biosciences, Durham University, South Road, Durham DH1 3LE, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,7,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","article-title":"Systemic sclerosis","volume":"390","author":"Denton","year":"2017","journal-title":"Lancet"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s11926-017-0630-3","article-title":"Innate Immunity in Systemic Sclerosis","volume":"19","author":"Dowson","year":"2017","journal-title":"Curr. Rheumatol. Rep."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/s00281-015-0503-7","article-title":"Role of innate immune system in systemic sclerosis","volume":"37","author":"Fullard","year":"2015","journal-title":"Semin. Immunopathol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.cytogfr.2012.04.003","article-title":"Interleukin-6, its role in fibrosing conditions","volume":"23","author":"Ciechomska","year":"2012","journal-title":"Cytokine Growth Factor Rev."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1172\/JCI31139","article-title":"Systemic sclerosis: A prototypic multisystem fibrotic disorder","volume":"117","author":"Varga","year":"2007","journal-title":"J. Clin. Investig."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.matbio.2005.07.002","article-title":"Interleukin 4 and prolonged hypoxia induce a higher gene expression of lysyl hydroxylase 2 and an altered cross-link pattern: Important pathogenetic steps in early and late stage of systemic scleroderma?","volume":"24","author":"Brinckmann","year":"2005","journal-title":"Matrix Biol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"15002","DOI":"10.1038\/nrdp.2015.2","article-title":"Systemic sclerosis","volume":"1","author":"Allanore","year":"2015","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.clim.2014.11.006","article-title":"METEORIN-LIKE is a cytokine associated with barrier tissues and alternatively activated macrophages","volume":"156","author":"Ushach","year":"2015","journal-title":"Clin. Immunol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1038\/aps.2016.70","article-title":"Intestinal Metrnl released into the gut lumen acts as a local regulator for gut antimicrobial peptides","volume":"37","author":"Li","year":"2016","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.cell.2014.03.065","article-title":"Meteorin-like Is a Hormone that Regulates Immune-Adipose Interactions to Increase Beige Fat Thermogenesis","volume":"157","author":"Rao","year":"2014","journal-title":"Cell"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"3669","DOI":"10.4049\/jimmunol.1800435","article-title":"Meteorin-like\/Meteorin-\u03b2 Is a Novel Immunoregulatory Cytokine Associated with Inflammation","volume":"201","author":"Ushach","year":"2018","journal-title":"J. Immunol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"108253","DOI":"10.1016\/j.clim.2019.108253","article-title":"The novel cytokine Metrnl\/IL-41 is elevated in Psoriatic Arthritis synovium and inducible from both entheseal and synovial fibroblasts","volume":"208","author":"Bridgewood","year":"2019","journal-title":"Clin. Immunol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e20201206","DOI":"10.1084\/jem.20201206","article-title":"Meteorin-like\/Meteorin-\u03b2 protects heart against cardiac dysfunction","volume":"218","author":"Florit","year":"2021","journal-title":"J. Exp. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.advms.2021.01.007","article-title":"Meteorin-like protein (METRNL)\/IL-41 improves LPS-induced inflammatory responses via AMPK or PPAR\u03b4\u2013mediated signaling pathways","volume":"66","author":"Jung","year":"2021","journal-title":"Adv. Med. Sci."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.cell.2006.01.016","article-title":"TOR signaling in growth and metabolism","volume":"124","author":"Wullschleger","year":"2006","journal-title":"Cell"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"14720","DOI":"10.18632\/aging.205268","article-title":"Meteorin-like protein elevation post-exercise improved vascular inflammation among coronary artery disease patients by downregulating NLRP3 inflammasome activity","volume":"15","author":"Liu","year":"2023","journal-title":"Aging"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s10787-023-01296-9","article-title":"PPAR\u03b3 partial agonist LPSF\/GQ-16 prevents dermal and pulmonary fibrosis in HOCl-induced systemic sclerosis (SSc) and modulates cytokine production in PBMC of SSc patients","volume":"32","author":"Dantas","year":"2024","journal-title":"Inflammopharmacology"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1096\/fj.08-128736","article-title":"Peroxisome proliferator-activated receptor-\u03b3 abrogates Smad-dependent collagen stimulation by targeting the p300 transcriptional coactivator","volume":"23","author":"Ghosh","year":"2009","journal-title":"FASEB J."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Ji, H., Dong, H., Lan, Y., Bi, Y., Gu, X., Han, Y., Yang, C., Cheng, M., and Gao, J. (2023). Metformin attenuates fibroblast activation during pulmonary fibrosis by targeting S100A4 via AMPK-STAT3 axis. Front. Pharmacol., 14.","DOI":"10.3389\/fphar.2023.1089812"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1038\/s41467-019-10839-0","article-title":"Metformin induces lipogenic differentiation in myofibroblasts to reverse lung fibrosis","volume":"10","author":"Kheirollahi","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"960","DOI":"10.7150\/ijms.32157","article-title":"Metformin Inhibits Epithelial-to-Mesenchymal Transition of Keloid Fibroblasts via the HIF-1\u03b1\/PKM2 Signaling Pathway","volume":"16","author":"Lei","year":"2019","journal-title":"Int. J. Med. Sci."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1159\/000491964","article-title":"Metformin Alleviates Radiation-Induced Skin Fibrosis via the Downregulation of FOXO3","volume":"48","author":"Kim","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1016\/j.jid.2016.05.097","article-title":"Oral Metformin Ameliorates Bleomycin-Induced Skin Fibrosis","volume":"136","author":"Ursini","year":"2016","journal-title":"J. Investig. Dermatol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/s12967-021-02860-z","article-title":"Metformin ameliorates scleroderma via inhibiting Th17 cells and reducing mTOR-STAT3 signaling in skin fibroblasts","volume":"19","author":"Moon","year":"2021","journal-title":"J. Transl. Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1016\/j.ajpath.2012.08.006","article-title":"Keloid disease can be inhibited by antagonizing excessive mTOR signaling with a novel dual TORC1\/2 inhibitor","volume":"181","author":"Syed","year":"2012","journal-title":"Am. J. Pathol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1093\/rheumatology\/key166","article-title":"2-Methoxyestradiol inhibits hypoxia-induced scleroderma fibroblast collagen synthesis by phosphatidylinositol 3-kinase\/Akt\/mTOR signalling","volume":"57","author":"Zhou","year":"2018","journal-title":"Rheumatology"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1002\/art.27498","article-title":"Treatment with rapamycin prevents fibrosis in tight-skin and bleomycin-induced mouse models of systemic sclerosis","volume":"62","author":"Yoshizaki","year":"2010","journal-title":"Arthritis Rheum."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/jcmm.13915","article-title":"Serum Metrnl is associated with the presence and severity of coronary artery disease","volume":"23","author":"Liu","year":"2019","journal-title":"J. Cell. Mol. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/s41423-021-00803-8","article-title":"Meteorin-\u03b2\/Meteorin like\/IL-41 attenuates airway inflammation in house dust mite-induced allergic asthma","volume":"19","author":"Gao","year":"2022","journal-title":"Cell. Mol. Immunol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/art.37738","article-title":"Tumor necrosis factor\u2013costimulated T lymphocytes from patients with systemic sclerosis trigger collagen production in fibroblasts","volume":"65","author":"Simpson","year":"2013","journal-title":"Arthritis Rheum."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1093\/rheumatology\/kes090","article-title":"T cells in systemic sclerosis: A reappraisal","volume":"51","year":"2012","journal-title":"Rheumatology"}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/13\/14\/1205\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:18:15Z","timestamp":1760109495000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/13\/14\/1205"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,17]]},"references-count":31,"journal-issue":{"issue":"14","published-online":{"date-parts":[[2024,7]]}},"alternative-id":["cells13141205"],"URL":"https:\/\/doi.org\/10.3390\/cells13141205","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,17]]}}}